Skip to main navigation Skip to search Skip to main content

Validation of the functional assessment of multiple sclerosis quality of life instrument

  • D. F. Cella*
  • , K. Dineen
  • , B. Arnason
  • , A. Reder
  • , K. A. Webster
  • , G. Karabatsos
  • , C. Chang
  • , S. Lloyd
  • , F. Mo
  • , J. Stewart
  • , D. Stefoski
  • *Corresponding author for this work
  • Rush University
  • Division of Psychosocial Oncology
  • The University of Chicago

Research output: Contribution to journalJournal Article peer-review

402 Scopus citations

Abstract

Based on scientific literature and interviews with clinicians and patients, we developed a quality of life instrument for use with people with MS called the Functional Assessment of Multiple Sclerosis (FAMS). The initial item pool consisted of 88 questions: 28 from the general version of the Functional Assessment of Cancer Therapy quality of life instrument, plus 60 generated by patients, providers, and literature review. The validation samples comprised a mail survey cohort (N = 377) and a clinical cohort (N = 56). Both cohorts provided evidence for internal consistency of the derived subscales, test-retest reliability, content validity, concurrent validity, and construct validity. Principal components and Rasch measurement model analyses were applied sequentially to survey sample data, reducing test length to 44 questions, divided into six subscales: mobility, symptoms, emotional well-being (depression), general contentment, thinking/fatigue, and family/social well-being. Fifteen initially rejected questions were added back as miscellaneous (unscored) questions for their potential clinical and empirical value. The mobility subscale was strongly predictive of the Kurtzke Extended Disability Status Scale and the Scripps Neurologic Rating Scales. The other five subscales were not, indicating they measure aspects of patient quality of life not captured by the neurologic exam. The final 59-item English language instrument (FAMS version 2) is available for inclusion in clinical trials and clinical practice.

Original languageEnglish
Pages (from-to)129-139
Number of pages11
JournalNeurology
Volume47
Issue number1
DOIs
StatePublished - 07 1996
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Validation of the functional assessment of multiple sclerosis quality of life instrument'. Together they form a unique fingerprint.

Cite this